Champlain reports 2.6% Transcat stake in 13G
Champlain Investment Partners, LLC filed a Schedule 13G reporting beneficial ownership of 241,996 shares of Transcat Inc. common stock, representing 2.6% of the outstanding class as of the event date.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Champlain Investment Partners, LLC filed a Schedule 13G reporting beneficial ownership of 241,996 shares of Transcat Inc. common stock, representing 2.6% of the outstanding class as of the event date.
Champlain has sole voting power over 228,026 shares and sole dispositive power over 241,996 shares, with no shared voting or dispositive power. The firm certifies the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Transcat.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Transcat Inc. (TRNS) does Champlain Investment Partners report?
What type of SEC filing did Champlain submit for Transcat Inc. (TRNS)?
Does Champlain intend to influence control of Transcat Inc. (TRNS)?
Why does Champlain’s Transcat (TRNS) holding appear on Schedule 13G if it is under 5%?
AI-generated analysis. How Rhea-AI works. Not financial advice.